Cargando…
Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
BACKGROUND: Highly variable results of topical diphenylcyclopropenone (DPCP) in the treatment of alopecia areata have been reported so far. The purposes of the present study were to evaluate the efficacy and tolerability of DPCP treatment in severe alopecia areata. METHODS: Twenty-eight patients (16...
Autor principal: | Aghaei, Shahin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1177937/ https://www.ncbi.nlm.nih.gov/pubmed/15918897 http://dx.doi.org/10.1186/1471-5945-5-6 |
Ejemplares similares
-
Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata
por: KUTLUBAY, Zekayi, et al.
Publicado: (2020) -
Treatment satisfaction and response in patients with severe alopecia areata under treatment with diphenylcyclopropenone
por: Abedini, Robabeh, et al.
Publicado: (2022) -
Comparative Study of Efficacy and Safety of Topical Squaric Acid Dibutylester and Diphenylcyclopropenone for the Treatment of Alopecia Areata
por: Tiwary, Anup K., et al.
Publicado: (2016) -
Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens
por: Nowicka, Danuta, et al.
Publicado: (2018) -
Topical diphenylcyclopropenone plus topical 0.5% anthralin versus topical diphenylcyclopropenone alone for the treatment of chronic extensive alopecia areata: A split-scalp, double-blind, controlled study
por: Thuangtong, Rattapon, et al.
Publicado: (2022)